Literature DB >> 21142443

Alternative translational reading frames as a novel source of epitopes for an expanded CD8 T-cell repertoire: use of a retroviral system to assess the translational requirements for CTL recognition and lysis.

Timothy L Carlson1, Kathy A Green, William R Green.   

Abstract

CD8 T-cell responses constitute a key host defense mechanism against tumor cells and a variety of viral infections, including retroviral infections that lead to acquired immunodeficiency. However, both for tumor cells and for many viral infections, there can be a relative paucity of immunodominant protective CD8 T-cell responses. For retroviruses, their rapid and error-prone replication, coupled with initial CD8 T-cell immunoselection of epitope-variant, retroviral quasi-species, are major impediments to sustaining a protective CD8 T-cell response. To approach this limitation of functional CD8 T-cell epitopes, here we further characterize an underappreciated source of additional T-cell epitopes: cryptic determinants, in particular those encoded in unconventional, alternative reading frames (ARFs). By use of the CD8 T-cell epitope, SYNTGRFPPL, which we have defined as encoded by the +1NT ARF of the gag gene of the LP-BM5 retrovirus that causes murine AIDS, we further characterize the regulation of ARF-epitope expression. Specifically, we examine the translation initiation requirements for production of sufficient epitope for effector CD8 T-cell recognition. Such translation must arise from rare frame-shifting events, making it crucial to understand any other constraints on epitope production, and therefore on the ability of the anti-Kd/SYNTGRFPPL CD8 T cells to protect from LP-BM5 pathogenesis and retroviral load, as we have previously shown. The data herein demonstrate that ARF epitope production depends entirely on conventional AUG-initiated translation, and that the more proximal in-frame ARF AUG is most important. However, maximal epitope production for protective CD8 T-cell lytic function also requires synergy of this initiation codon with a counterpart conventional AUG codon upstream in the same ARF (ORF 2), and with the classic ORF 1 AUG that initiates conventional gag polyprotein translation. These results have implications for the design of ARF-epitope-based vaccines, both to counter retroviral pathogenesis, as well as potentially more broadly, including in tumor systems.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142443      PMCID: PMC2991181          DOI: 10.1089/vim.2010.0057

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  34 in total

1.  Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism.

Authors:  S Malarkannan; T Horng; P P Shih; S Schwab; N Shastri
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  Constitutive display of cryptic translation products by MHC class I molecules.

Authors:  Susan R Schwab; Katy C Li; Chulho Kang; Nilabh Shastri
Journal:  Science       Date:  2003-09-05       Impact factor: 47.728

Review 3.  Alternative translational products and cryptic T cell epitopes: expecting the unexpected.

Authors:  On Ho; William R Green
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

4.  Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.

Authors:  S M Mayrand; P A Healy; B E Torbett; W R Green
Journal:  Virology       Date:  2000-07-05       Impact factor: 3.616

5.  A novel influenza A virus mitochondrial protein that induces cell death.

Authors:  W Chen; P A Calvo; D Malide; J Gibbs; U Schubert; I Bacik; S Basta; R O'Neill; J Schickli; P Palese; P Henklein; J R Bennink; J W Yewdell
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

6.  Role of a cytotoxic-T-lymphocyte epitope-defined, alternative gag open reading frame in the pathogenesis of a murine retrovirus-induced immunodeficiency syndrome.

Authors:  Arti Gaur; William R Green
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Cryptic CTL epitope on a murine sarcoma Meth A generated by exon extension as a novel mechanism.

Authors:  Akiko Uenaka; Yoshiki Hirano; Hidenori Hata; Sanda Win; Toshiki Aji; Motoyuki Tanaka; Toshiro Ono; Jonathan C A Skipper; Kenji Shimizu; Eiichi Nakayama
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

8.  Defining the mechanism(s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame.

Authors:  Melanie R Rutkowski; On Ho; William R Green
Journal:  Virology       Date:  2009-06-18       Impact factor: 3.616

9.  Systematic search fails to detect immunogenic MHC class-I-restricted determinants encoded by influenza A virus noncoding sequences.

Authors:  Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  Virology       Date:  2003-01-05       Impact factor: 3.616

10.  AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape.

Authors:  Nicholas J Maness; Laura E Valentine; Gemma E May; Jason Reed; Shari M Piaskowski; Taeko Soma; Jessica Furlott; Eva G Rakasz; Thomas C Friedrich; David A Price; Emma Gostick; Austin L Hughes; John Sidney; Alessandro Sette; Nancy A Wilson; David I Watkins
Journal:  J Exp Med       Date:  2007-10-22       Impact factor: 14.307

View more
  3 in total

Review 1.  Targeting frameshifting in the human immunodeficiency virus.

Authors:  Léa Brakier-Gingras; Johanie Charbonneau; Samuel E Butcher
Journal:  Expert Opin Ther Targets       Date:  2012-03       Impact factor: 6.902

2.  Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency.

Authors:  Kathy A Green; W James Cook; William R Green
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

3.  The role of indoleamine 2,3-dioxygenase in LP-BPM5 murine retroviral disease progression.

Authors:  Megan A O'Connor; William R Green
Journal:  Virol J       Date:  2013-05-17       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.